Angelico, Mario

Publishing since 1985 (Dinosaur)

Has published 101 publications in 26 years

Number of publications published per year by Angelico, Mario. (Source : PubMed)

Distribution of publications types for Angelico, Mario. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression.  Dig Liver Dis  2010;42;4  
•  Orlacchio A, Mancini A, Calabrese G, Bolacchi F, Cozzolino V, Angelico M, Simonetti G. Portal vein thrombosis after radiofrequency ablation of HCC.  Minerva Gastroenterol Dietol  2010;56;1  
•  Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis.  Dig Liver Dis  2010  
•  Angelico M. One year of editorship: are we there yet?  Dig Liver Dis  2009;41;12  
•  Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M. Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.  Eur J Public Health  2009  
•  Baiocchi L, Lenci I, Carbone M, Angelico M. Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".  Hepatology  2009;50;5  
•  Orlando G, Tariciotti L, Manzia TM, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke GM, Soker S, Baiocchi L, Lerut J, Angelico M, Tisone G. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia.  Transplant infectious disease : an official journal of the Transplantation Society  2009  
•  Angelico F, Francioso S, Del Ben M, Feole K, Carbone M, Pignatelli P, Violi F, Angelico M. Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients.  Aliment. Pharmacol. Ther.  2009;30;5  
•  Piccolo P, Lenci I, Demelia L, Bandiera F, Piras MR, Antonucci G, Nosotti L, Mari T, De Santis A, Ponti ML, Sorbello O, Iacomi F, Angelico M. A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.  Antivir. Ther. (Lond.)  2009;14;8  
•  Angelico M. Looking ahead without forgetting the past.  Dig Liver Dis  2009;41;1  

[ See timeline ] [ See all publications ]